2011
DOI: 10.1097/olq.0b013e31820cb166
|View full text |Cite
|
Sign up to set email alerts
|

Extracts of Canadian First Nations Medicinal Plants, Used as Natural Products, Inhibit Neisseria gonorrhoeae Isolates With Different Antibiotic Resistance Profiles

Abstract: Canadian botanicals represent a potential source of novel compounds which inhibit Ng, including isolates resistant to antibiotics.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
16
0
1

Year Published

2012
2012
2024
2024

Publication Types

Select...
7
3

Relationship

0
10

Authors

Journals

citations
Cited by 32 publications
(17 citation statements)
references
References 21 publications
0
16
0
1
Order By: Relevance
“…For example, the activities of many of these have not been examined against XDR or MDR gonococcal isolates, particularly those with ESC resistance or high-level azithromycin resistance. Furthermore, despite the fact that a breakthrough is lacking, as part of "thinking outside the box," it can be important to continuously evaluate appropriate plant extracts for in vitro activity against gonococci and, subsequently, for treatment of gonorrhea (136,(333)(334)(335)(336)(337)(338)(339)(340)(341)(342)(343)(344)(345). All novel potential treatment regimens for gonorrhea require up-to-date and comprehensive in vitro and, subsequently, in vivo evaluations, including appropriately designed, randomized, and controlled clinical trials to evaluate parameters such as efficacy, safety, toxicity, cost, optimal dose, and pharmacokinetic/pharmacodynamic data for genital and extragenital (especially pharyngeal) gonorrhea.…”
Section: Future Perspectives For Treatmentmentioning
confidence: 99%
“…For example, the activities of many of these have not been examined against XDR or MDR gonococcal isolates, particularly those with ESC resistance or high-level azithromycin resistance. Furthermore, despite the fact that a breakthrough is lacking, as part of "thinking outside the box," it can be important to continuously evaluate appropriate plant extracts for in vitro activity against gonococci and, subsequently, for treatment of gonorrhea (136,(333)(334)(335)(336)(337)(338)(339)(340)(341)(342)(343)(344)(345). All novel potential treatment regimens for gonorrhea require up-to-date and comprehensive in vitro and, subsequently, in vivo evaluations, including appropriately designed, randomized, and controlled clinical trials to evaluate parameters such as efficacy, safety, toxicity, cost, optimal dose, and pharmacokinetic/pharmacodynamic data for genital and extragenital (especially pharyngeal) gonorrhea.…”
Section: Future Perspectives For Treatmentmentioning
confidence: 99%
“…Berberine -an alkaloid isolated from plants of Berberidaceae family and present in numerous natural sources has its place in traditional medicine, and is believed to be a remedy for fungal and bacterial infections [245,246] as well as for cancer [247,248]. Current clinical trials are concentrated on the use of berberine in the treatment of polycystic ovary syndrome and on its effects on diabetes.…”
Section: Azanaphthalenes Under Clinical Trialsmentioning
confidence: 99%
“…This plant is furnished with setae and found in cold and lofty situations of the mountains [18]. Research work on other species of this plant indicates anti-inflammatory, [19], antibacterial, [20] and anti-arthritis [21] activities. Other species of the genus Gaultheria like G.yunnanensis , G. fragrantissima and G. procumbens are used in traditional medicine to treat arthritis in China, India, America and Canada.…”
Section: Introductionmentioning
confidence: 99%